COVID-19変異株が免疫システムを回避する仕組みを解明(Scientists Uncover How COVID-19 Variants Outsmart the Immune System)

ad

2025-11-21 マウントサイナイ医療システム(MSHS)

研究チームは、SARS-CoV-2の多数の抗体–スパイクタンパク質構造を1,000件以上集め、「抗体がウイルス表面をどのように覆っているか」「変異株がどのように抗体結合を弱めているか」という“構造地図”を作成しました。解析により、多くの臨床用抗体がスパイクの受容体結合領域(RBD)を標的としており、変異によって抗体結合が弱まることで変異株(例:オミクロン)が免疫逃避を達成する仕組みが明らかになりました。また、ナノボディのようにスパイクの深部を捉える分子が変異株でも有効である可能性が示され、今後の抗体設計やワクチン開発に向けた「変異耐性治療」の設計指針を提供しています。研究成果は、免疫系の強みと限界を可視化し、次世代治療のための地図を描くものです。

COVID-19変異株が免疫システムを回避する仕組みを解明(Scientists Uncover How COVID-19 Variants Outsmart the Immune System)
Above: Cartoon model of the SARS-CoV-2 spike protein showing the different regions (or domains) that are associated with known viral mutations and antibodies can recognize and attach to. These include areas involved in binding to human cells and in helping the virus fuse with them. Image credit: Feng, et al., Cell Systems.

<関連情報>

1000のSARS-CoV-2抗体構造が収束結合とほぼ普遍的な免疫回避を明らかに One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape

Zirui Feng ∙ Zhe Sang ∙ Yufei Xiang ∙ … ∙ Dina Schneidman-Duhovny ∙ Adolfo García-Sastre ∙ Yi Shi
Cell Systems  Published:November 21, 2025
DOI:https://doi.org/10.1016/j.cels.2025.101452

Highlights

  • Structural atlas of >1,100 SARS-CoV-2 antibody complexes (16% of all antibody structures)
  • 99% of receptor-binding domain surface residues targeted by antibodies
  • >96% of epitopes and 1/3 of epitope residues mutated; only rare survivors retain binding
  • Surviving nanobodies bind highly conserved sites yet show limited neutralization

Summary

Understanding antibody recognition and adaptation to viral evolution is central to vaccine and therapeutic development. Over 1,100 SARS-CoV-2 antibody structures have been resolved, marking the largest structural biology effort for a single pathogen. We present a comprehensive analysis of this landmark dataset to investigate the principles of antibody recognition and immune escape. Human immunoglobulins and camelid single-chain antibodies dominate, collectively mapping 99% of the receptor-binding domain. Despite remarkable sequence and conformational diversity, antibodies exhibit convergence in their paratope structures, revealing evolutionary constraints in epitope selection. Analyses reveal near-universal immune escape of antibodies, including all clinical monoclonals, by advanced variants such as KP3.1.1. On average, over one-third of antibody epitope residues are mutated. These findings support pervasive immune escape, underscoring the need to effectively leverage multi-epitope-targeting strategies to achieve durable immunity. To support community accessibility, we developed an interactive web server for visualization and analysis of antibody-antigen complexes and mutational data.

有機化学・薬学
ad
ad
Follow
ad
タイトルとURLをコピーしました